News
Biotech firms assess the impact of Trump's new order on drug pricing
US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align with the lowest prices paid in those countries. He framed the move as a long-overdue correction to "decades of unfair pricing," claiming that US consumers have been subsidizing drug costs globally.
One estimate of the profit hit from Trump's executive order on drug pricing
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels could result in 15% operating profit cuts in the industry.
STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent ...
11d
Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Indeed, shares of the three ...
Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...
The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its [tariff rollout]( ...
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...
16h
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower ...
According to the timeline laid out in President Donald Trump’s May 12 executive order, prescription drug price reductions would not happen "almost immediately." The order specifies a 30-day period to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback